AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $109,000 | +67.7% | 95,350 | +35.5% | 0.00% | – |
Q2 2023 | $65,000 | +62.5% | 70,350 | 0.0% | 0.00% | – |
Q1 2023 | $40,000 | +17.6% | 70,350 | +18.4% | 0.00% | – |
Q4 2022 | $34,000 | +112.5% | 59,425 | +14.2% | 0.00% | – |
Q3 2022 | $16,000 | 0.0% | 52,024 | +13.8% | 0.00% | – |
Q2 2022 | $16,000 | -54.3% | 45,724 | -6.1% | 0.00% | – |
Q1 2022 | $35,000 | -68.2% | 48,682 | -0.0% | 0.00% | – |
Q4 2021 | $110,000 | -22.0% | 48,693 | 0.0% | 0.00% | – |
Q3 2021 | $141,000 | -24.6% | 48,693 | -0.9% | 0.00% | -100.0% |
Q2 2021 | $187,000 | +12.0% | 49,143 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $167,000 | +20.1% | 49,143 | -0.7% | 0.00% | 0.0% |
Q4 2020 | $139,000 | +6.1% | 49,485 | -10.1% | 0.00% | 0.0% |
Q3 2020 | $131,000 | -73.4% | 55,037 | +51.8% | 0.00% | -66.7% |
Q2 2020 | $493,000 | +81.9% | 36,256 | +1.3% | 0.00% | +50.0% |
Q1 2020 | $271,000 | +19.9% | 35,806 | 0.0% | 0.00% | +100.0% |
Q4 2019 | $226,000 | +242.4% | 35,806 | +111.5% | 0.00% | – |
Q3 2019 | $66,000 | -16.5% | 16,931 | +4.7% | 0.00% | – |
Q2 2019 | $79,000 | – | 16,177 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |